These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37870869)

  • 1. The use of Tocilizumab in COVID-19 critically ill patients with renal impairment: a multicenter, cohort study.
    Aljuhani O; Al Sulaiman K; B Korayem G; Alharbi A; Altebainawi AF; Aldkheel SA; Alotaibi SG; Vishwakarma R; Alshareef H; Alsohimi S; AlFaifi M; Al Shaya A; Alhaidal HA; Alsubaie RM; Alrashidi H; Albarqi KJ; Alangari DT; Alanazi RM; Altaher NM; Al-Dorzi HM
    Ren Fail; 2023; 45(2):2268213. PubMed ID: 37870869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Early Tocilizumab Effect on Multiorgan Dysfunction in Critically Ill Patients With COVID-19: A Propensity Score-Matched Study.
    Aljuhani O; Korayem GB; Altebainawi AF; Al Harthi A; Badreldin HA; Alsalloum MA; Eljaaly K; Alharbi A; Aljehani R; Vishwakarma R; Alenazi AA; Alalawi M; Alissa A; Al Aamer K; Al Enazi H; Almusallam M; Alshehri A; Bukhari R; Alasmari G; AlQahtani MM; Al Shammari S; Alsulaymi HO; Al Sulaiman K
    J Intensive Care Med; 2023 Jun; 38(6):534-543. PubMed ID: 36683420
    [No Abstract]   [Full Text] [Related]  

  • 3. The safety and effectiveness of tocilizumab in older adult critically ill patients with COVID-19: a multicenter, cohort study.
    Korayem GB; Aljuhani O; Altebainawi AF; Shaya AIA; Alnajjar LI; Alissa A; Aldhaeefi M; Kensara R; Al Muqati H; Alhuwahmel A; Alhuthaili O; Vishwakarma R; Aldardeer N; Eljaaly K; Alharbi A; Harbi SA; Katheri AA; Bekairy AMA; Aljedai A; Al Sulaiman K
    Int J Infect Dis; 2022 Sep; 122():252-259. PubMed ID: 35605948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study.
    Al Sulaiman K; Korayem GB; Altebainawi AF; Al Harbi S; Alissa A; Alharthi A; Kensara R; Alfahed A; Vishwakarma R; Al Haji H; Almohaimid N; Al Zumai O; Alrubayan F; Asiri A; Alkahtani N; Alolayan A; Alsohimi S; Melibari N; Almagthali A; Aljahdali S; Alenazi AA; Alsaeedi AS; Al Ghamdi G; Al Faris O; Alqahtani J; Al Qahtani J; Alshammari KA; Alshammari KI; Aljuhani O
    Crit Care; 2022 Oct; 26(1):304. PubMed ID: 36192801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between tocilizumab therapy and the development of thrombosis in critically ill patients with COVID-19: a multicenter, cohort study.
    Aljuhani O; Al Sulaiman K; Korayem GB; Altebainawi AF; Alsohimi S; Alqahtani R; Alfaifi S; Alharbi A; AlKhayrat A; Hattan A; Albassam M; Almohammed OA; Alkeraidees A; Alonazi DA; Alsalman WF; Aldamegh G; Alshahrani R; Vishwakarma R
    Sci Rep; 2024 Feb; 14(1):3037. PubMed ID: 38321099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney Recovery and Death in Critically Ill Patients With COVID-19-Associated Acute Kidney Injury Treated With Dialysis: The STOP-COVID Cohort Study.
    Hsu CM; Gupta S; Tighiouart H; Goyal N; Faugno AJ; Tariq A; Raichoudhury R; Sharma JH; Meyer L; Kshirsagar RK; Jose A; Leaf DE; Weiner DE;
    Am J Kidney Dis; 2022 Mar; 79(3):404-416.e1. PubMed ID: 34871701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of Mortality and Major Adverse Kidney Events in Critically Ill Patients With Acute Kidney Injury.
    Neyra JA; Ortiz-Soriano V; Liu LJ; Smith TD; Li X; Xie D; Adams-Huet B; Moe OW; Toto RD; Chen J
    Am J Kidney Dis; 2023 Jan; 81(1):36-47. PubMed ID: 35868537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of tocilizumab therapy in critically ill patients with severe acute respiratory syndrome coronavirus 2.
    Saffo Z; Guo W; Springer K; Maksimowicz-McKinnon K; Kak V; McKinnon JE; Bhargava P
    J Osteopath Med; 2021 Jul; 121(8):705-714. PubMed ID: 34237804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19.
    Gupta S; Wang W; Hayek SS; Chan L; Mathews KS; Melamed ML; Brenner SK; Leonberg-Yoo A; Schenck EJ; Radbel J; Reiser J; Bansal A; Srivastava A; Zhou Y; Finkel D; Green A; Mallappallil M; Faugno AJ; Zhang J; Velez JCQ; Shaefi S; Parikh CR; Charytan DM; Athavale AM; Friedman AN; Redfern RE; Short SAP; Correa S; Pokharel KK; Admon AJ; Donnelly JP; Gershengorn HB; Douin DJ; Semler MW; Hernán MA; Leaf DE;
    JAMA Intern Med; 2021 Jan; 181(1):41-51. PubMed ID: 33080002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and outcome of critically ill COVID-19 patients with acute kidney injury: a single centre cohort study.
    Lowe R; Ferrari M; Nasim-Mohi M; Jackson A; Beecham R; Veighey K; Cusack R; Richardson D; Grocott M; Levett D; Dushianthan A;
    BMC Nephrol; 2021 Mar; 22(1):92. PubMed ID: 33722189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When antivirals backfire: An evaluation of favipiravir's clinical outcomes in critically ill patients with COVID-19: A multicenter cohort study.
    Al Sulaiman K; Aljuhani O; Korayem GB; Altebainawi AF; AlFaifi M; Nahari M; Almagthali A; Thabit AK; Alhajaji R; Alharbi R; Kahtani K; Alenazi AA; Alharbi A; Alghwainm MM; Alotaibi SM; Alghamdi YS; Alotaibi S; Alonazi SH; Almutairi JM; Vishwakarma R
    J Infect Public Health; 2023 Sep; 16(9):1492-1499. PubMed ID: 37355406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute Kidney Injury and Renal Replacement Therapy in Critically Ill COVID-19 Patients: Risk Factors and Outcomes: A Single-Center Experience in Brazil.
    Doher MP; Torres de Carvalho FR; Scherer PF; Matsui TN; Ammirati AL; Caldin da Silva B; Barbeiro BG; Carneiro FD; Corrêa TD; Ferraz LJR; Dos Santos BFC; Pereira VG; Batista MC; Monte JCM; Santos OFP; Bellomo R; Serpa Neto A; Durão MS
    Blood Purif; 2021; 50(4-5):520-530. PubMed ID: 33341806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Tocilizumab in Management of COVID-19 Patients Admitted to Intensive Care Units: A Multicenter Retrospective Cohort Study.
    Ibrahem HY; Aly DH; Warda AEA; Farahat RA; Youssef RM; Abdelhamid MH; Goud HA; Mohamed RR; Eldien MAYN; Alotaibi FO; Alzarea AI; Alanazi AS; Eisa NM; Refaee AS
    Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676678
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of early initiation of continuous renal replacement therapy based on the KDIGO classification on the prognosis of critically ill patients with acute kidney injury].
    Chen M; Hu B; Li Q; Liu J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Mar; 28(3):246-51. PubMed ID: 29917340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Low-Dose Aspirin use among Critically Ill Patients with COVID-19: A Multicenter Propensity Score Matched Study.
    Al Harthi AF; Aljuhani O; Korayem GB; Altebainawi AF; Alenezi RS; Al Harbi S; Gramish J; Kensara R; Hafidh A; Al Enazi H; Alawad A; Alotaibi R; Alshehri A; Alhuthaili O; Vishwakarma R; Bin Saleh K; Alsulaiman T; Alqahtani RA; Hussain S; Almazrou S; Al Sulaiman K
    J Intensive Care Med; 2022 Sep; 37(9):1238-1249. PubMed ID: 35450493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the use of methylprednisolone and dexamethasone in asthma critically ill patients with COVID-19: a multicenter cohort study.
    Al Sulaiman K; Aljuhani O; Korayem GB; Altebainawi A; Alharbi R; Assadoon M; Vishwakarma R; Ismail NH; Alshehri AA; Al Mutairi FE; AlFaifi M; Alharthi AF; Alenazi AA; Alalawi M; Al Zumai O; Al Haji H; Al Dughaish ST; Alawaji AS; Alhaidal HA; Al Ghamdi G
    BMC Pulm Med; 2023 Aug; 23(1):315. PubMed ID: 37641042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early recovery status and outcomes after sepsis-associated acute kidney injury in critically ill patients.
    Luo X; Yan P; Zhang N; Wang M; Deng Y; Wu T; Wu X; Liu Q; Wang H; Wang L; Kang Y; Duan S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 May; 47(5):535-545. PubMed ID: 35753723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Observational study on off-label use of tocilizumab in patients with severe COVID-19.
    Albertini L; Soletchnik M; Razurel A; Cohen J; Bidegain F; Fauvelle F; Safrano G; Piquet J; Maurer C; Goldgran-Toledano D
    Eur J Hosp Pharm; 2021 Jan; 28(1):22-27. PubMed ID: 32912961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Early vs Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute Kidney Injury: The ELAIN Randomized Clinical Trial.
    Zarbock A; Kellum JA; Schmidt C; Van Aken H; Wempe C; Pavenstädt H; Boanta A; Gerß J; Meersch M
    JAMA; 2016 May 24-31; 315(20):2190-9. PubMed ID: 27209269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Inhaled Corticosteroids (ICS) in Critically Ill Patients With COVID-19: A Multicenter, Cohort Study.
    Al Sulaiman K; Aljuhani O; Al Aamer K; Al Shaya O; Al Shaya A; Alsaeedi AS; Alhubaishi A; Altebainawi AF; Al Harthi A; Albelwi S; Almutairi R; Alsubaie N; Alsallum A; Korayem GB; Alfahed A; Kensara R; Altebainawi EF; Alenezi RS; Alsulaiman T; Al Enazi H; Vishwakarma R; Al Dabbagh T; Bakhsh U; Al Ghamdi G
    J Intensive Care Med; 2022 Feb; 37(2):248-257. PubMed ID: 34757869
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.